THE 2-MINUTE RULE FOR LX-2931

Pharmacological inhibition of the ataxia telangiectasia and Rad3-linked protein serine/threonine kinase (ATR; often called FRAP-linked protein (FRP1)) has emerged like a promising system for cancer treatment that exploits synthetic lethal interactions with proteins linked to DNA problems mend, overcomes resistance to other therapies and boosts anti